Pulse biosciences, inc. (PLSE)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Operating expenses:
General and administrative

23,529

22,327

18,967

19,036

19,063

20,045

22,032

20,791

19,542

15,503

10,729

7,374

4,115

3,299

2,689

2,018

1,596

1,224

0

0

0

Research and development

25,300

24,961

23,451

22,297

19,920

17,253

15,037

12,924

11,094

9,646

8,431

7,059

6,359

5,622

4,924

4,030

3,147

2,578

0

0

0

Amortization of intangible assets

665

666

665

665

666

665

665

665

665

665

666

666

665

665

665

666

666

666

0

0

0

Total operating expenses

49,494

47,954

43,083

41,998

39,649

37,963

37,734

34,380

31,301

25,814

19,826

15,099

11,139

9,586

8,278

6,714

5,409

4,468

0

0

0

Other income:
Interest income

729

983

975

875

722

446

439

360

264

247

153

145

107

68

0

0

0

-

-

-

-

Other

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

729

983

947

847

694

418

439

360

264

247

153

145

107

68

0

0

0

-

-

-

-

Loss from operations, before income taxes

-

-46,971

-42,136

-41,151

-

-37,545

-37,295

-34,020

-31,037

-25,567

-19,673

-14,954

-11,032

-9,518

-8,244

-6,711

-5,409

-4,468

0

0

0

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,358

-1,657

0

0

0

Net loss

-48,765

-46,971

-42,136

-41,151

-38,955

-37,545

-37,295

-34,020

-31,037

-25,567

-19,673

-14,954

-11,032

-9,518

-7,726

-5,710

-4,051

-2,811

0

0

0

Other comprehensive loss:
Unrealized gain on available-for-sale securities

15

5

11

22

5

50

-1

6

6

-44

6

-6

0

0

0

-

0

-

-

-

-

Comprehensive loss

-48,750

-46,966

-42,125

-41,129

-38,950

-37,495

-37,296

-34,014

-31,031

-25,611

-19,667

-14,960

-11,041

-9,525

-7,734

-5,710

-4,051

-2,811

0

0

0

Net loss per share:
Basic and diluted net loss per share

-0.57

-0.66

-0.57

-0.55

-0.49

-0.51

-0.64

-0.54

-0.51

-0.53

-0.52

-0.43

-0.23

-0.21

-0.21

-0.23

-0.22

-0.13

-0.10

-0.08

-0.06

Weighted average shares used to compute net loss per common share - basic and diluted

20,838

20,799

20,774

20,728

20,679

17,656

16,927

16,881

16,842

16,574

14,381

14,233

13,803

13,315

13,315

9,791

7,565

7,565

7,565

7,565

7,565